old A$38.9m, now minus 56% which I think is still generous...at $17.2m
Compare that to uber ramper @wombat777 who had his retailer based fantasy NPAT estimate at A$1 Billion. A hearted poster with multiple top MSB posts, all in fantasy land as I have posted many times even before FDA "delay".
Beware the HC piped pipers.
whilst Bell Potter likely much closer to the mark than any uber ramper will ever be, I would temper that with an observation.
Bell Potter have reduced NPAT obviously...and shuffled around some balance sheet items 1. for FY21 by -56% and 2. for FY22 by - 90%
Yet adjusted "valuation" from $7.30 to just $7..... Yeh, righto.
**and a special mention for my mate @benelong TEMCELL royalties expected to be MINUS 32% for FY21 over FY20.
MSB Price at posting:
$3.41 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)